Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Bearish
4
Neutral
3
Bullish
7
Bearish
36
Neutral
3
Bullish
7
Bearish
32
Neutral
0
Bullish
0
Investor Presentation
Q1 FY17
Investor Presentation
Q4 FY16
Investor Presentation
Q3 FY16

Market Cap
₹ 40 Cr
P/E
—
Pharmaceuticals
Pharmaceuticals - Indian - Bulk Drugs & Formln M/S
40 Cr
High Risk
—
30.8
—
0.3
129.90
23.77
Sales CAGR
1Y
-13.66%
3Y
-10.98%
5Y
0.32%
10Y
0.54%
Profit CAGR
1Y
174.09%
3Y
-29.38%
5Y
-3.45%
10Y
-8.91%
ROE
TTM
-15.52%
3Y
-0.19%
5Y
6.46%
10Y
8.95%
ROCE
TTM
-2.61%
3Y
6.96%
5Y
13.99%
10Y
17.80%
Performance
UNDER PERFORMER
Valuation
REASONABLE
Growth
STABLE
Profitability
MODERATE MARGIN
Technicals
Bearish
Risk
MODERATE RISK